Upcoming Webinars
Harnessing the Power of Primary Market Research & Competitive Intelligence using AI
Presented by MathCo
January 21, 2026 @ 12:00 PM Eastern
Pharmaceutical organizations conduct many primary market research studies and collect huge amounts of competitive intelligence every year. Most of this information sits in silos with different teams and only a few are aware of specific information in the documents which takes a long time to get to the right sources and the latest information when needed. With GenAI, organizations can break the silos and disseminate this information freely among the relevant teams and company leadership. With all this information just one query away, the time to insights is drastically cut down enabling faster decisions for brands.
Pharma organizations have struggled to leverage enterprise tools to unlock the potential of market research and competitive intelligence due to lack of context in search summarization, industry terminology, and therapeutic areas with specific nuances. In this session, we will walk through our systemic AI approach to transform insights into action for primary market research and competitive intelligence through customized architecture solutions involving orchestrator agents, metadata extraction, context mapping, evaluation metrics and robust integration of information sources.
Speakers:
Bala Arunachalam, Director, Integrated Analytics and Insights, Novo Nordisk
Dr. Alicia Abella, AI Product Leader, Novo Nordisk
Shyam Vora, Associate Principal, AI Products, MathCo
Abhinav Nigam, Associate Principal, Life Sciences Consulting, MathCo
Moderator: Ashwin Gopalakrishnan, Partner, Head of Life Sciences, Math Co
Powering biopharma launches with a strong commercial data foundation
Presented by ZS
February 11, 2026 @ 12:00 PM Eastern
As biopharma companies prepare for product launches in increasingly complex and competitive markets, the strength of their commercial data foundation has become a critical driver of success. Fragmented data, delayed insights, and limited cross-functional alignment can undermine launch execution, slow decision-making, and restrict the ability to scale effectively post-launch.
In this session, Nicholas Ruhl, Director, Commercial Data Operations and Insights at Apellis and Vismit Sharma, Associate Partner, Platform and Products at ZS, will share practical, real-world perspectives on how biopharma organizations can build a robust, scalable commercial data foundation that supports both launch readiness and sustained in-market performance.
Attendees will learn:
- Why a strong commercial data foundation is essential for successful biopharma launches and long-term growth
- How to align data, analytics, and commercial operations to enable launch readiness and rapid scale-up
- Common data and operational challenges biopharma companies face before and after launch—and proven approaches to overcome them
- How to move from siloed reporting to real-time, actionable commercial insights
- How platforms like ZAIDYN® can drive success from pre-launch through in-market growth, with a modular, AI-ready platform that helps optimize commercial operations for measurable impact
This discussion is designed for commercial, analytics, and launch leaders at biopharma companies who are preparing for an upcoming launch or looking to strengthen and scale their commercial capabilities post-launch.
Speakers:
Nicholas Ruhl, Director, Commercial Data Operations and Insights, Apellis
Vismit Sharma, Associate Partner, Platform and Products, ZS
Moderator: Jared Keckeisen, ZS